Our Australian Partner received their first batch of IDS-1100 Dermatoscope :: illuco ::
An estimated 134,000 new cases of cancer will be diagnosed in Australia this year, with that number set to rise to 150,000 by 2020. Skin cancers found and removed early are almost always curable. We hope IDS-1100 Dermatoscope will become the new influential diagnostic force in Dermatoscopy and also in Australia.
IDS-1100, Dermatoscopy, Dermatoscope, Skin Cancer, Australia, Dermatology, Diagnostic Device, ILLUCO
8827
single,single-post,postid-8827,single-format-standard,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.3,wpb-js-composer js-comp-ver-4.12.1,vc_responsive
Australia_1stBatch_Newsletter_03

Our Australian Partner received their first batch of IDS-1100 Dermatoscope

  |   Company News   |   No comment

Our Australian Partner received their first batch of IDS-1100 in May 2017.

Australia_1stBatch_Newsletter_03An estimated 134,000 new cases of cancer will be diagnosed in Australia this year,

with that number set to rise to 150,000 by 2020.

Skin cancers found and removed early are almost always curable.

We hope IDS-1100 Dermatoscope will become

the new influential diagnostic force in Dermatoscopy and also in Australia.

AUTHOR - illuco

No Comments

Post A Comment